Shen, Jiazhen
Varshney, Dhaval
Simeone, Angela
Zhang, Xiaoyun
Adhikari, Santosh
Tannahill, David
Balasubramanian, Shankar http://orcid.org/0000-0002-0281-5815
Funding for this research was provided by:
Cancer Research UK (C9545/A19836)
Cancer Research UK (C9681/A29214)
Wellcome Trust (209441/Z/17/Z)
Herchel Smith Funds
Article History
Received: 8 December 2020
Accepted: 9 April 2021
First Online: 7 May 2021
Declarations
:
: Ethics approval was not needed for the experiments performed in this study.
: S.B. is a founder and shareholder of Cambridge Epigenetix Ltd. The other authors declare that they have no competing interests.